Log in
Enquire now
NKILT Therapeutics

NKILT Therapeutics

NKILT Therapeutics, Inc., is a new cell therapy biotech developing a novel approach of engineering Natural Killer (NK) cells, and other immune cells, to directly target leukemias and solid tumors.

OverviewStructured DataIssuesContributors

Contents

nkilt.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Immunotherapy
Immunotherapy
Tissue engineering
Tissue engineering
Cell therapy
Cell therapy
‌
Allogeneic cell therapy
Biotechnology
Biotechnology
Regenerative medicine
Regenerative medicine
Healthcare
Healthcare
CEO
Raphaël G. Ognar
Raphaël G. Ognar
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like NKILT Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Become an Editor
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us

Explore companies

  • Artificial Intelligence
  • Fintech
  • Biotechnology
  • Cybersecurity
  • Semiconductors
  • Electric Vehicles
  • Cloud Computing
  • Robotics
  • SaaS
  • Renewable Energy
  • Venture Capital
  • Blockchain
  • Browse all →
By using this site, you agree to our Terms of Service.